TATA Health International Holdings Limited (HKSE: 1255.HK) Stock Competitors & Peer Comparison
See 1255.HK's competitors and their performance on the HKSE and across the wider stock market.
Peer Comparison Table: Apparel - Footwear & Accessories Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for 1255.HK and its HKSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 1255.HK | HK$2.19 | -0.23% | 533M | -23.29 | -HK$0.09 | N/A |
| 2313.HK | HK$41.14 | -0.68% | 61B | 9.53 | HK$4.26 | +6.35% |
| 0551.HK | HK$13.65 | -1.09% | 21.9B | 7.35 | HK$1.86 | +9.51% |
| 1910.HK | HK$13.20 | -1.57% | 18.1B | 8.56 | HK$1.55 | +6.02% |
| 1440.HK | HK$12.75 | -5.06% | 16.6B | -15348.84 | -HK$0.00 | N/A |
| 1836.HK | HK$14.15 | -0.77% | 11.9B | 11.00 | HK$1.28 | +10.28% |
| 1361.HK | HK$4.93 | +5.68% | 10.4B | 6.34 | HK$0.76 | +6.60% |
| 1028.HK | HK$1.12 | +4.67% | 2.8B | 44.45 | HK$0.02 | N/A |
| 3813.HK | HK$0.37 | -1.33% | 1.9B | 6.34 | HK$0.06 | +14.67% |
| 1657.HK | HK$50.75 | +0.69% | 1.6B | -84.58 | -HK$0.60 | N/A |
Stock Comparison
Shenzhou International Group Holdings Limited (HKSE: 2313.HK)
1255.HK vs 2313.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 2313.HK has a market cap of 61B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 2313.HK trades at HK$41.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 2313.HK's P/E ratio is 9.53. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 2313.HK's ROE of +0.16%. Regarding short-term risk, 1255.HK is more volatile compared to 2313.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 2313.HK's competition here
Yue Yuen Industrial (Holdings) Limited (HKSE: 0551.HK)
1255.HK vs 0551.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 0551.HK has a market cap of 21.9B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 0551.HK trades at HK$13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 0551.HK's P/E ratio is 7.35. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 0551.HK's ROE of +0.07%. Regarding short-term risk, 1255.HK is more volatile compared to 0551.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 0551.HK's competition here
Samsonite International S.A. (HKSE: 1910.HK)
1255.HK vs 1910.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1910.HK has a market cap of 18.1B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1910.HK trades at HK$13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1910.HK's P/E ratio is 8.56. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1910.HK's ROE of +0.17%. Regarding short-term risk, 1255.HK is more volatile compared to 1910.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1910.HK's competition here
Star Shine Holdings Group Limited (HKSE: 1440.HK)
1255.HK vs 1440.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1440.HK has a market cap of 16.6B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1440.HK trades at HK$12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1440.HK's P/E ratio is -15348.84. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1440.HK's ROE of -0.40%. Regarding short-term risk, 1255.HK is less volatile compared to 1440.HK. This indicates lower risk in terms of short-term price fluctuations for 1255.HK.Check 1440.HK's competition here
Stella International Holdings Limited (HKSE: 1836.HK)
1255.HK vs 1836.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1836.HK has a market cap of 11.9B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1836.HK trades at HK$14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1836.HK's P/E ratio is 11.00. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1836.HK's ROE of +0.09%. Regarding short-term risk, 1255.HK is more volatile compared to 1836.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1836.HK's competition here
361 Degrees International Limited (HKSE: 1361.HK)
1255.HK vs 1361.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1361.HK has a market cap of 10.4B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1361.HK trades at HK$4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1361.HK's P/E ratio is 6.34. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1361.HK's ROE of +0.13%. Regarding short-term risk, 1255.HK is more volatile compared to 1361.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1361.HK's competition here
C.banner International Holdings Limited (HKSE: 1028.HK)
1255.HK vs 1028.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1028.HK has a market cap of 2.8B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1028.HK trades at HK$1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1028.HK's P/E ratio is 44.45. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1028.HK's ROE of -0.14%. Regarding short-term risk, 1255.HK is more volatile compared to 1028.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1028.HK's competition here
Pou Sheng International (Holdings) Limited (HKSE: 3813.HK)
1255.HK vs 3813.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 3813.HK has a market cap of 1.9B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 3813.HK trades at HK$0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 3813.HK's P/E ratio is 6.34. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 3813.HK's ROE of +0.03%. Regarding short-term risk, 1255.HK is more volatile compared to 3813.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 3813.HK's competition here
SG Group Holdings Limited (HKSE: 1657.HK)
1255.HK vs 1657.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1657.HK has a market cap of 1.6B. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1657.HK trades at HK$50.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1657.HK's P/E ratio is -84.58. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1657.HK's ROE of -0.09%. Regarding short-term risk, 1255.HK is more volatile compared to 1657.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1657.HK's competition here
China International Development Corporation Limited (HKSE: 0264.HK)
1255.HK vs 0264.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 0264.HK has a market cap of 951.7M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 0264.HK trades at HK$1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 0264.HK's P/E ratio is -48.58. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 0264.HK's ROE of +0.46%. Regarding short-term risk, 1255.HK is more volatile compared to 0264.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 0264.HK's competition here
China Anchu Energy Storage Group Limited (HKSE: 2399.HK)
1255.HK vs 2399.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 2399.HK has a market cap of 936.4M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 2399.HK trades at HK$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 2399.HK's P/E ratio is -2.35. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 2399.HK's ROE of -0.87%. Regarding short-term risk, 1255.HK is more volatile compared to 2399.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 2399.HK's competition here
Prosperous Industrial (Holdings) Limited (HKSE: 1731.HK)
1255.HK vs 1731.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1731.HK has a market cap of 851.2M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1731.HK trades at HK$0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1731.HK's P/E ratio is 3.66. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1731.HK's ROE of +0.13%. Regarding short-term risk, 1255.HK is more volatile compared to 1731.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1731.HK's competition here
Pegasus International Holdings Limited (HKSE: 0676.HK)
1255.HK vs 0676.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 0676.HK has a market cap of 738M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 0676.HK trades at HK$1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 0676.HK's P/E ratio is -89.70. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 0676.HK's ROE of -0.06%. Regarding short-term risk, 1255.HK is more volatile compared to 0676.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 0676.HK's competition here
Daphne International Holdings Limited (HKSE: 0210.HK)
1255.HK vs 0210.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 0210.HK has a market cap of 672.7M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 0210.HK trades at HK$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 0210.HK's P/E ratio is 5.92. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 0210.HK's ROE of +0.14%. Regarding short-term risk, 1255.HK is less volatile compared to 0210.HK. This indicates lower risk in terms of short-term price fluctuations for 1255.HK.Check 0210.HK's competition here
Golden Solar New Energy Technology Holdings Limited (HKSE: 1121.HK)
1255.HK vs 1121.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1121.HK has a market cap of 654.3M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1121.HK trades at HK$0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1121.HK's P/E ratio is -1.84. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1121.HK's ROE of -1.09%. Regarding short-term risk, 1255.HK is less volatile compared to 1121.HK. This indicates lower risk in terms of short-term price fluctuations for 1255.HK.Check 1121.HK's competition here
Mainland Headwear Holdings Limited (HKSE: 1100.HK)
1255.HK vs 1100.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1100.HK has a market cap of 592.2M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1100.HK trades at HK$1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1100.HK's P/E ratio is 10.49. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1100.HK's ROE of +0.10%. Regarding short-term risk, 1255.HK is more volatile compared to 1100.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1100.HK's competition here
Time Watch Investments Limited (HKSE: 2033.HK)
1255.HK vs 2033.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 2033.HK has a market cap of 489.8M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 2033.HK trades at HK$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 2033.HK's P/E ratio is -10.25. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 2033.HK's ROE of -0.02%. Regarding short-term risk, 1255.HK is more volatile compared to 2033.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 2033.HK's competition here
Sitoy Group Holdings Limited (HKSE: 1023.HK)
1255.HK vs 1023.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1023.HK has a market cap of 444.1M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1023.HK trades at HK$0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1023.HK's P/E ratio is -8.34. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1023.HK's ROE of -0.06%. Regarding short-term risk, 1255.HK is more volatile compared to 1023.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1023.HK's competition here
Kingmaker Footwear Holdings Limited (HKSE: 1170.HK)
1255.HK vs 1170.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1170.HK has a market cap of 266.8M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1170.HK trades at HK$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1170.HK's P/E ratio is -13.94. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1170.HK's ROE of -0.07%. Regarding short-term risk, 1255.HK is more volatile compared to 1170.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1170.HK's competition here
Le Saunda Holdings Limited (HKSE: 0738.HK)
1255.HK vs 0738.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 0738.HK has a market cap of 232.7M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 0738.HK trades at HK$0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 0738.HK's P/E ratio is -3.45. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 0738.HK's ROE of -0.14%. Regarding short-term risk, 1255.HK is less volatile compared to 0738.HK. This indicates lower risk in terms of short-term price fluctuations for 1255.HK.Check 0738.HK's competition here
Namyue Holdings Limited (HKSE: 1058.HK)
1255.HK vs 1058.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1058.HK has a market cap of 223.3M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1058.HK trades at HK$0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1058.HK's P/E ratio is -6.60. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1058.HK's ROE of -1.92%. Regarding short-term risk, 1255.HK is more volatile compared to 1058.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1058.HK's competition here
Suncorp Technologies Limited (HKSE: 1063.HK)
1255.HK vs 1063.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1063.HK has a market cap of 100M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1063.HK trades at HK$0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1063.HK's P/E ratio is -11.02. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1063.HK's ROE of +0.14%. Regarding short-term risk, 1255.HK is more volatile compared to 1063.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1063.HK's competition here
Jimu Group Limited (HKSE: 8187.HK)
1255.HK vs 8187.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 8187.HK has a market cap of 80.4M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 8187.HK trades at HK$0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 8187.HK's P/E ratio is -5.93. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 8187.HK's ROE of -1.05%. Regarding short-term risk, 1255.HK is more volatile compared to 8187.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 8187.HK's competition here
Grown Up Group Investment Holdings Limited (HKSE: 1842.HK)
1255.HK vs 1842.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1842.HK has a market cap of 44.4M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1842.HK trades at HK$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1842.HK's P/E ratio is -10.00. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1842.HK's ROE of -0.22%. Regarding short-term risk, 1255.HK is less volatile compared to 1842.HK. This indicates lower risk in terms of short-term price fluctuations for 1255.HK.Check 1842.HK's competition here
Sling Group Holdings Limited (HKSE: 8285.HK)
1255.HK vs 8285.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 8285.HK has a market cap of 21.8M. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 8285.HK trades at HK$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 8285.HK's P/E ratio is -5.42. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 8285.HK's ROE of +0.04%. Regarding short-term risk, 1255.HK is more volatile compared to 8285.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 8285.HK's competition here
Sino Energy International Holdings Group Limited (HKSE: 1096.HK)
1255.HK vs 1096.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1096.HK has a market cap of 0. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1096.HK trades at HK$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1096.HK's P/E ratio is -0.16. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1096.HK's ROE of +0.65%. Regarding short-term risk, 1255.HK is more volatile compared to 1096.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1096.HK's competition here
Vestate Group Holdings Limited (HKSE: 1386.HK)
1255.HK vs 1386.HK Comparison August 2026
TATA Health International Holdings Limited (HKSE: 1255.HK) plays a significant role within the Consumer Cyclical sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1255.HK stands at 533M. In comparison, 1386.HK has a market cap of 0. Regarding current trading prices, 1255.HK is priced at HK$2.19 on the HKSE, while 1386.HK trades at HK$0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1255.HK currently has a P/E ratio of -23.29, whereas 1386.HK's P/E ratio is N/A. In terms of profitability, 1255.HK's ROE is -0.26%, compared to 1386.HK's ROE of +0.77%. Regarding short-term risk, 1255.HK is more volatile compared to 1386.HK. This indicates higher risk in terms of short-term price fluctuations for 1255.HK.Check 1386.HK's competition here